Home › Germany's Merck cautious after deal spree
 

Keywords :   


Germany's Merck cautious after deal spree

2015-03-03 10:15:59| Chemicals - Topix.net

Germany's Merck KGaA forecasts little or no improvement in earnings this year after a slight drop in fourth-quarter net profit, with stiff competition for its blockbuster multiple-sclerosis treatment and higher research spending likely to offset the impact of recent acquisitions. Multiple-sclerosis drug Rebif faces strong competition in North America and Europe while Merck continues to spend on developing new cancer treatments.

Tags: deal cautious merck spree

Category:Chemicals

Latest from this category

All news
05.11Teknos Poland Honored by Farby i Lakiery
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
04.11Registration Open for 2025 Waterborne Symposium
04.11ROSS Ribbon Blenders Provide Safe, Efficient Bulk Blending
04.11U.S. Green Building Council Announces 2024 Leadership Award Recipients
04.11ASTM International Publishes New Standards for FT4 Powder Rheometer Procedures
04.11Nippon Paint Marine Uses Biomimetics to Unlock Next Generation in Hull Coatings
04.11AkzoNobels Yacht Brands Lead the Way in Digital Training and Support
Chemicals »
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
05.11Teknos Poland Honored by Farby i Lakiery
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 7
05.11Tropical Storm Rafael Public Advisory Number 7
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 7
05.11Boeing strike ends as workers back 38% pay rise deal
More »